2861202-76-6
2861202-76-6
Chemical Structure
Nirmatrelvir-d9
Synonym(s): PF-07321332-d9
- CAS No.: 2861202-76-6
- Formula:C23H23D9F3N5O4
- Molecular Weight:508.58
IUPAC Name: methyl 2-(3-fluoro-2-((2-methyl-2-(1H-pyrazol-1-yl)propyl)carbamoyl)benzyl)acrylate
InChIKey: SLFMNMOGPWGWLC-UHFFFAOYSA-N
SMILES: O=C(NCC1)[C@@H]1C[C@@H](C#N)NC([C@@H]2[C@]3([H])[C@@](CN2C([C@H](C(C([2H])([2H])[2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])NC(C(F)(F)F)=O)=O)([H])C3(C)C)=O
Biological Activity: Nirmatrelvir-d9 (PF-07321332-d9) is the deuterium labeled Nirmatrelvir (HY-138687)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Nirmatrelvir-d9 | 99.93% | Nirmatrelvir-d9 (PF-07321332-d9) is the deuterium labeled Nirmatrelvir (HY-138687). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Nirmatrelvir (Standard) | 99.98% | Nirmatrelvir (Standard) is the analytical standard of Nirmatrelvir. This product is intended for research and analytical applications. Nirmatrelvir (PF-07321332) is a potent and orally active SARS-CoV 3C-like protease (3CLPRO) inhibitor. Nirmatrelvir (PF-07321332) targets to the SARS-CoV-2 virus and can be used for COVID-19 research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Deunirmatrelvir | Deunirmatrelvir is a deuterium labeled compound. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Nirmatrelvir-d6 | Nirmatrelvir-d6 (PF-07321332-d6) is deuterium labeled Nirmatrelvir. Nirmatrelvir (PF-07321332) is a potent and orally active SARS-CoV 3C-like protease (3CLPRO) inhibitor. Nirmatrelvir (PF-07321332) targets to the SARS-CoV-2 virus and can be used for COVID-19 research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Nirmatrelvir | 99.74% | Nirmatrelvir (PF-07321332) is a potent and orally active SARS-CoV 3C-like protease (3CLPRO) inhibitor. Nirmatrelvir (PF-07321332) targets to the SARS-CoV-2 virus and can be used for COVID-19 research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
